| [1]DeFrancesco-Lisowitz A, Lindborg JA, Niemi JP,et al. The neuroimmunology of degeneration and regeneration in the peripheral nervous system. Neuroscience. 2015;302: 174-203.[2]Gilley J, Coleman MP. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons.Endogenous Nmnat 2 is an essential survival factor for maintenance of healthy axons.PLoS biol.2010;8:e1000300 .[3]Gilley J, Adalbert R, Yu G,et al. Rescue of peripheral and CNS axon defects in mice lacking Nmnat 2. J Neurosci. 2013; 33(33): 13410-13424.[4]Wang JT, Medress ZA, Vargas ME,et al.Local axonal protection by WldS as revealed by conditional regulation of protein stability. Proc Natl Acad Sci U S A. 2015;112:10093- 10100.[5]Sasaki Y, Araki T,Milbrandt J.Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neurosci. 2006;26(33):8484-91..[6]Loreto A, Di Stefano M, Gering M,et al. Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca(2+) Influx but Only Modestly Influenced by Mitochondria. Cell Rep. 2015 22;13(11):2539-2552.[7]Di Stefano M, Nascimento-Ferreira I, Orsomando G, et al.A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ. 2015;22(5):731-742.[8]Sasaki Y,Vohra BP, Lund FE,et al.Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci. 2009;29(17):5525-5535.[9]Wang J, Zhai Q, Chen Y,et al. A local mechanism mediates NAD -dependent protection of axon degeneration. J Cell Biol. 2005;170(3):349-355.[10]Araki T, Sasaki Y,MilbrandtJ. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science. Science. 2004;305(5686):1010- 1013.[11]Osterloh JM, Yang J, Rooney TM,et al.dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science. Science. 2012;337(6093):481-484[12]Gerdts J, Summers DW, Sasaki Y, et al.Sarm1-mediated axon degeneration requires both SAM and TIR interactions.J Neurosci. 2013;33(33):13569-13580.[13]Kuan CY, Whitmarsh AJ, Yang DD, et al.A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci U S A. Proc Natl Acad Sci U S A. 2003;100(25):15184-15189.[14]Vargas ME,Yamagishi Y.Live Imaging of Calcium Dynamics during Axon Degeneration Reveals Two Functionally Distinct Phases of Calcium Influx. 2015;35:15026-15038.[15]Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Phil. Trans. R. Soc. Lond.1850;140:423-429.[16]Lunn ER,Perry VH,Brown MC,et al.Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve. Eur J Neurosci. 1989;1(1):27-33. [17]Deckwerth TL,Johnson EM Jr. Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Developmental biology.1994；165：63-72.[18]Beirowski B, Adalbert R, Wagner D, et al.The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci. 2005;6:6.[19]Chang B, Quan Q, Lu S,et al. Molecular mechanisms in the initiation phase of Wallerian degeneration. Eur J Neurosci. 2016 ;44(4):2040-2048.[20]O'Donnell KC,Vargas ME,Sagasti A.WldS and PGC-1alpha regulate mitochondrial transport and oxidation state after axonal injury. J Neurosci. 2013 ;33(37):14778-14790.[21]Avery MA, Rooney TM, Pandya JD, et al.WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.Current biology. Curr Biol. 2012 10;22(7):596-600.[22]Beirowski B, Babetto E, Coleman MP,et al.The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur J Neurosci. 2008;28(6):1166-1179.[23]Wang MS, Davis AA, Culver DG,et al.WldS mice are resistant to paclitaxel (taxol) neuropathy. Annals Neurology.2002; 52: 442-447.[24]Laser H, Conforti L, Morreale G, et al.The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Molecular biology of the cell. Mol Biol Cell. 2006;17(3):1075-1084.[25]Babetto E, Beirowski B, Janeckova L,et al.Targeting Nmnat 1 to axons and synapses transforms its neuroprotective potency in vivo. J Neurosci. 2010;30(40):13291-1304.[26]Sasaki Y, Vohra BP, Baloh RH,et alTransgenic mice expressing the Nmnat 1 protein manifest robust delay in axonal degeneration in vivo. J Neurosci. 2010;30(40):13291-304.[27]Beirowski B, Babetto E, Gilley J,et al. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci. 2009 ;29(3):653-668.[28]Conforti L, Gilley J,Coleman MP.Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci. 2014;15(6):394-409..[29]Felici R,Lapucci A, Ramazzotti M,et al. Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria. PLoS One. 2013;8(10):e76938.[30]Yamamoto M, Hikosaka K, Mahmood A, et al.Nmnat3 Is Dispensable in Mitochondrial NAD Level Maintenance In Vivo. PLoS One. 2016;11(1):e0147037.[31]Conforti L, Janeckova L, Wagner D, et al. Reducing expression of DNA+ synthesizing enzyme Nmnat 1 does not affect the rate of Wallerian degeneration. FEBS J. 2011; 278(15): 2666-2679.[32]Zhai RG, Cao Y, Hiesinger PR,et al.Drosophila Nmnat maintains neural integrity independent of its DNA synthesis activity. PLoS biology. PLoS Biol. 2006;4(12):e416.[33]Verdin E. DNA + in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213.[34]Mack TG, Reiner M, Beirowski B,et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/ Nmnat chimeric gene.Nature neuroscience.2001;4(12):1199-206.[35]Gerdts J,Brace EJ, Sasaki Y,et al. Neurobiology. SARM1 activation triggers axon degeneration locally via DNA(+) destruction. Science. 2015;348:453-457.[36]Conforti L, Wilbrey A, Morreale G,et al. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol. 2009;184(4):491-500.[37]Milde S, Gilley J,Coleman MP.Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat 2. PLoS Biol. 2013;11(4): e1001539.[38]Xiong X, Hao Y, Sun K, et al.The Highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein. PLoS Biol. 2012;10(12):e1001440.[39]Babetto E, Beirowski B, Russler EV, et al. The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction.Cell reports.2013;3:1422-1429.[40]Gilley J, Orsomando G, Nascimento-Ferreira I,et al. Absence of SARM1 rescues development and survival of Nmnat 2-deficient axons. Cell Rep. 2015;10(12):1974-1981.[41]Yang J, Wu Z, Renier N, et al.Pathological axonal death through a MAPK cascade that triggers a local energy deficit. Cell Cell. 2015;160(1-2):161-176.[42]Schlaepfer WW. Effects of energy deprivation on Wallerian degeneration in isolated segments of rat peripheral nerve. Brain research.1974;78:71-81.[43]Summers DW, DiAntonio A,Milbrandt J.Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons. J Neurosci. 2014;34(28):9338-9350.[44]Ikegami K,Koike T. Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience.2003;122, 617-626.[45]Alvarez S, Moldovan M,Krarup C. Acute energy restriction triggers Wallerian degeneration in mouse. Experimental neurology.2008;212:166-178.[46]Villegas R, Martinez NW, Lillo J, et al.Calcium release from intra-axonal endoplasmic reticulum leads to axon degeneration through mitochondrial dysfunction. J Neurosci. 2014 ;34(21):7179-7189.[47]Zala D, Hinckelmann MV, Yu H, et al.Vesicular glycolysis provides on-board energy for fast axonal transport.Cell. 2013;152(3):479-491. [48]Zheng J, Sun J, Lu X, et al.BDNF promotes the axonal regrowth after sciatic nerve crush through intrinsic neuronal capability upregulation and distal portion protection. Neurosci Lett. 2016;621:1-8.[49]Quan Q, Chang B, Meng HY, et al. Use of electrospinning to construct biomaterials for peripheral nerve regeneration. Rev Neurosci. 2016;27(7):761-768. .[50]Gu X, Ding F,Williams DF. Neural tissue engineering options for peripheral nerve regeneration. Biomaterials.2014;35: 6143-6156.[51]Wang CY, Zhang KH, Fan CY,et al.Aligned natural-synthetic polyblend nanofibers for peripheral nerve regeneration. Acta Biomater. 2011;7(2):634-643.[52]Madduri S,Papaloizos M,Gander B.Trophically and topographically functionalized silk fibroin nerve conduits for guided peripheral nerve regeneration. Biomaterials.2009; 31:2323-2334.[53]Deister C,Schmidt CE.Optimizing neurotrophic factor combinations for neurite outgrowth. J Neural Eng. 2006; 3(2):172-179.[54]Cattin AL, Burden JJ, Van Emmenis L, et al.Macrophage-Induced Blood Vessels Guide Schwann Cell-Mediated Regeneration of Peripheral Nerves. Cell.2015;162:1127-1139.[55]Greenberg DA,Jin K. From angiogenesis to neuropathology. Nature.2005;438: 954-959.[56]Madduri S, di Summa P, Papaloizos M, et al. Effect of controlled co-delivery of synergistic neurotrophic factors on early nerve regeneration in rats. Biomaterials.2010;31:8402-8409.[57]Daly W, Yao L, Zeugolis D, et al. A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery. J R Soc Interface. 2012;9(67):202-221.[58]McGrath AM, Novikova LN, Novikov LN,et al. BD PuraMatrix peptide hydrogel seeded with Schwann cells for peripheral nerve regeneration. Brain research bulletin.2010;83:207-213.[59]Oliveira JT, Almeida FM, Biancalana A, et al. Mesenchymal stem cells in a polycaprolactone conduit enhance median-nerve regeneration, prevent decrease of creatine phosphokinase levels in muscle, and improve functional recovery in mice. Neuroscience. 2010;170(4):1295-1303.[60]di Summa PG, Kingham PJ, Raffoul W, et al.Adipose-derived stem cells enhance peripheral nerve regeneration.J Plast Reconstr Aesthet Surg. 2010;63(9):1544-1552.[61]Khalifian S, Sarhane KA, Tammia M,et al.Stem cell-based approaches to improve nerve regeneration: potential implications for reconstructive transplantation? Arch Immunol Ther Exp (Warsz). 2015;63(1):15-30.[62]Ikeda M, Uemura T, Takamatsu K, et al.Acceleration of peripheral nerve regeneration using nerve conduits in combination with induced pluripotent stem cell technology and a basic fibroblast growth factor drug delivery system. J Biomed Mater Res A. 2014;102(5):1370-1378.[63]Gu X, Ding F,Yang Y,et al. Construction of tissue engineered nerve grafts and their application in peripheral nerve regeneration. Progress in neurobiology.2011;93: 204-230.[64]Gu Y, Zhu J, Xue C,et al.Chitosan/silk fibroin-based, Schwann cell-derived extracellular matrix-modified scaffolds for bridging rat sciatic nerve gaps. Biomaterials. 2014;35(7):2253-2263.[65]Zhu S, Liu J, Zheng C, et al.Analysis of human acellular nerve allograft reconstruction of 64 injured nerves in the hand and upper extremity: a 3 year follow-up study. J Tissue Eng Regen Med. 2016 Apr 21..[66]Qiu T, Yin Y, Li B, Xie L, et al.PDLLA/PRGD/beta-TCP conduits build the neurotrophin-rich microenvironment suppressing the oxidative stress and promoting the sciatic nerve regeneration.J Biomed Mater Res A. 2014;102(10):3734-3743.[67]Xu X, Yee WC, Hwang PY, et al.Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. Biomaterials. 2003;24(13):2405-2412.[68]Hobson MI.Increased vascularisation enhances axonal regeneration within an acellular nerve conduit. Ann R Coll Surg Engl. 2002;84(1):47-53.[69]Piquilloud G,Christen T,Pfister LA,et al.Variations in glial cell line-derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs. Eur J Neurosci. 2007 ;26(5): 1109-1117.[70]Wood MD, MacEwan MR, French AR, et al. Fibrin matrices with affinity-based delivery systems and neurotrophic factors promote functional nerve regeneration. Biotechnol Bioeng. 2010;106(6):970-979.[71]Shen H, Shen ZL, Zhang PH,et al.Ciliary neurotrophic factor-coated polylactic-polyglycolic acid chitosan nerve conduit promotes peripheral nerve regeneration in canine tibial nerve defect repair. J Biomed Mater Res B Appl Biomater. 2010;95(1):161-170.[72]Hernández-Cortés P, Toledo-Romero MA, Delgado M, et al.Peripheral nerve reconstruction with epsilon-caprolactone conduits seeded with vasoactive intestinal peptide gene-transfected mesenchymal stem cells in a rat model.J Neural Eng. 2014;11(4):046024. [73]Santiago LY,Clavijo-Alvarez J,Brayfield C,et al.Delivery of adipose-derived precursor cells for peripheral nerve repair. Cell Transplant. 2009;18(2):145-58.[74]Ladak A, Olson J,Tredget EE,et al.Differentiation of mesenchymal stem cells to support peripheral nerve regeneration in a rat model.Exp Neurol. 2011;228(2):242-252. |
.jpg)
.jpg)
.jpg)